Antimicrobials News

Personal protective equipment and other supplies made using 3D printers may be “readily contaminated” with nosocomial pathogens and are best for one-time use, researchers reported.

The FDA’s Antimicrobial Drugs Advisory Committee voted unanimously in favor of approving sulbactam-durlobactam for adults with hospital-acquired and ventilator-associated bacterial pneumonia, Innoviva announced Monday.

As the product of two hard-working academic physicians, I have never been without incredible examples of leaders in the field of medicine.

SEATTLE — Antibiotic use in long-term care facilities declined significantly over the course of almost a decade, although there was an uptick in 2020 at the beginning of the COVID-19 pandemic, a study found.

SEATTLE — Prior nonprescription antibiotic use within the last year predicted similar use in the future, according to data presented at the Society for Healthcare Epidemiology of America Spring Conference.

SEATTLE — In this video, Infectious Disease News Editorial Board Member Keith S. Kaye, MD, MPH, talks about antimicrobial stewardship as a place to develop leadership skills.

Candida auris is an emerging multidrug-resistant yeast causing nosocomial infections. First identified in 2009 in Japan, C. auris has now also been isolated in North America, South America, Europe, Africa, the Middle East and East Asia.

A bactericidal nasal gel administered during the 24 hours before cardiac surgery reduced the burden of Staphylococcus aureus carriage vs. placebo with no adverse events or surgical site infections, researchers reported.

The FDA approved rezafungin for injection to treat candidemia and invasive candidiasis in adults, offering a new treatment for people with limited or no other options.

My journey in infectious diseases started out with an intense hatred and utter confusion.